Immvention Therapeutix is partnering with Novo Nordisk to develop oral treatments for sickle cell disease (SCD) and other chronic conditions.

In a move that the company, said demonstrates its commitment to investing in higher growth areas, Zimmer Biomet Holdings Inc. reported its plans to buy foot and ankle (F&A) orthopedic specialist ...

After hours: 7:59:52 p.m. EST Loading Chart for NVO ...

After hours: 7:44:37 pm GMT-5 ...

After hours: 8:00:00 pm GMT-5 Loading Chart for NVO ...

California Institute for Regenerative Medicine (CIRM) has awarded a $5.8 million translational research grant to a scientist at the University of California, Los Angeles (UCLA) to further support the ...